Skip to content

The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma

The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma (Propeller Health)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03860519
Enrollment
100
Registered
2019-03-04
Start date
2018-03-07
Completion date
2019-08-01
Last updated
2020-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, uncontrolled asthma, asthma medication adherence, Propeller Health, Connected Inhaler System

Brief summary

This is a behavioral randomized controlled trial of adults with uncontrolled persistent asthma that tests if the Propeller Health sensor, mobile application, and dashboard can improve adherence to ICS.

Interventions

BEHAVIORALElectronic Medication Monitors on ICS and SABA - Active Mode

The patients in the intervention group will have sensors that are active, so that these patients receive reminders about when to use their inhalers medications.

BEHAVIORALElectronic Medication Monitors on ICS and SABA - Silent Mode

The patients in the control group will have sensors that are silent, so that these patients do not receive reminders about when to use their inhalers medications.

BEHAVIORALAsthma App Tracking of ICS/SABA Usage - Active Mode

Patients in the intervention group will have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.

BEHAVIORALAsthma App Tracking of ICS/SABA Usage - Silent Mode

Patients in the control group will not have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.

BEHAVIORALNorthShore Connect Real Time ICS and SABA Usage Feedback - Yes

Patients in the intervention will receive feedback from the Research Nurse about their medication use and asthma control status.

BEHAVIORALNorthShore Connect Real Time ICS and SABA Usage Feedback - No

Patients in the intervention will not receive feedback from the Research Nurse about their medication use and asthma control status.

BEHAVIORALAsthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - Yes

Patients in the intervention group will receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.

BEHAVIORALAsthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - No

Patients in the control group will not receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Under the care of a staff asthma physician (i.e. pulmonologist or allergist/immunologist) at NorthShore University HealthSystem (NS) * Have an active NorthShore Connect (patient portal) account * Persistent uncontrolled asthma in the past 12 months * Active prescription for daily ICS medication for asthma

Exclusion criteria

* candidate refusal * the presence of other co-morbidities (e.g. severe psychiatric disorder) that could interfere with study participation

Design outcomes

Primary

MeasureTime frameDescription
Change in Short Acting Bronchodilator Medication use in Group with Propeller Health Platform Digital Technology Turned On vs Group with Propeller Health Platform Digital Technology Turned Off3.5 monthsUse of the Propeller Health Platform in the treatment group in active mode, compared to the attention control group in silent mode, will demonstrate a 20% change in SABA use and/or minimal clinically important difference (three points) change on the ACT and/or change from ACT score ≤ 19 to ≥20, at 3-months. The 20% change in SABA use = 20 point change (e.g. if a participants uses SABA 40% of days over the 2 week run-in period, and they change SABA use to 20% of days during the final 14 days of the active treatment period, that will equal a 20 point change. If SABA use changes from 40% of days over the 2- week run-in period to 32% of days during the final 14 days of the active treatment period, this will not be considered a 20 point change).

Secondary

MeasureTime frameDescription
Participant and clinician satisfaction as assessed by brief post-study survey of Propeller Health Platform Digital Technology3.5 monthsStudy staff developed a brief survey using open-ended questions (i.e. 20 questions, no scales used, no minimum or maximum scores are applicable) to ask participants and clinicians whether they were satisfied using the Propeller Health Platform Digital Technology. Standardized instruments are not being used.
Inhaled Corticosteroid Medication taking Behavior in the Group using Propeller Health Platform Digital Technology Turned On vs Group using Propeller Health Platform Digital Technology Turned Off3 monthsTo determine if two Propeller Health Platform Digital Technology arms (i.e. Arm #1= Technology in active on mode and Arm #2= Technology in passive off mode) demonstrate a change in inhaled corticosteroid medication taking behavior at 3 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026